Merck

Go Boldly: We Can Grow Our Business While Protecting the Health of Our Planet

by Danielle Menture, Vice President, Global Safety and the Environment
Blog

In September 2015, the 193 Member States of the United Nations came together to create a plan for achieving a better future for all. Their goal is an ambitious one — they want to help end extreme poverty, fight inequality and injustice, and protect our planet. This proposal is called “Agenda 2030” and is comprised of 17 Sustainable Development Goals (SDGs) which clearly define how to help create a better world. Fulfilling these SDGs will take an unprecedented effort, and for business they represent an opportunity to benefit society while growing and sustaining our business.

Merck Advances Clean Energy Goals with Invenergy

Press Release

KENILWORTH, N.J., April 17, 2018 – Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Invenergy, North America’s largest privately held renewable energy company, today announced a Virtual Power Purchase Agreement (VPPA) that adds 60 megawatts (MW) of renewable energy to the electrical grid and supports Merck’s environmental sustainability goals.

Merck Receives 2018 ENERGY STAR Sustained Excellence Award From U. S. Environmental Protection Agency

Company Receives EPA Honor for 13th Consecutive Year
Press Release

KENILWORTH, N.J., April 2, 2018 /3BL Media/ – Merck (NYSE: MRK), known as MSD outside the United States and Canada, announced today that it has received an ENERGY STAR 2018 Partner of the Year – Sustained Excellence Award from the U.S. Environmental Protection Agency (EPA) for its continued leadership in energy management in both the pharmaceutical and industrial sectors, and superior contributions to ENERGY STAR.  Merck’s accomplishments will be recognized by the EPA and the U.S. Department of Energy at a ceremony in Washington, D.C. on April 20, 2018.

Merck Chairman and CEO Ken Frazier Honored with Ronald H. Brown American Journey Award

Multimedia with summary

On March 23, Merck Chairman and CEO Ken Frazier received the Ronald H. Brown American Journey Award. The award, given annually, honors outstanding Americans who exemplify the vision and transformative ideals of Ron Brown, the first African-American U.S.

Making Waves: the Strategic Investor Initiative's CEO Investor Forum

SII Vantage Point Volume 2, Issue 2: Into the “Mainstream”
Newsletter

The third CEO Investor Forum, held on February 26 in New York City, has received a lot of attention in the media as the effort to end short-termism on Wall Street gains increasing traction.

Merck Earns Place on 2018 List of Top Companies for Executive Women

Press Release

KENILWORTH, N.J., March 9, 2018 /3BL Media/ -- The National Association for Female Executives (NAFE) named Merck as one of its 2018 NAFE Top Companies for Executive Women. The award recognizes U.S. corporations where women have significant clout to make the decisions that affect their company’s future and its bottom line. The NAFE Top 70 Companies are featured in the April/May issue of Working Mother.

Looking Beyond Next Quarter’s Results, 5 Global CEOs Share Long-Term Strategic Plans

To end “short-termism” on Wall Street, CEOs present plans for 3+ years out to investors representing $25 trillion in AUM
Press Release

NEW YORK, February 28, 2018 /3BL Media/ - CEOs from some of the most prominent companies in the world--including Johnson & Johnson, Medtronic, Merck, Unilever, and UPS -- came together to share their long-term business plans to an audience of more than 275 major institutional investors at the third CEO Investor Forum (CIF) organized by the CECP’s Strategic Investor Initiative (SII).

Ferring Pharmaceuticals and Merck Announce Completion of Largest Clinical Trial Ever Conducted in Postpartum Hemorrhage

Summary: 
  • Excessive Bleeding after Childbirth (Postpartum Hemorrhage or PPH) is the Leading Direct Cause of Maternal Mortality Worldwide
     
  • The CHAMPION Trial is Assessing the Effectiveness and Safety of Heat-Stable Carbetocin versus Oxytocin, the Current Standard of Care, for Preventing PPH After Vaginal Birth
Press Release
  • Excessive Bleeding after Childbirth (Postpartum Hemorrhage or PPH) is the Leading Direct Cause of Maternal Mortality Worldwide
     
  • The CHAMPION Trial is Assessing the Effectiveness and Safety of Heat-Stable Carbetocin versus Oxytocin, the Current Standard of Care, for Preventing PPH After Vaginal Birth

Merck for Mothers Blog | A Note from Dr. Etiebet: Reflections from WEF 2018

Blog

The MSD for Mothers team recently returned from the World Economic Forum annual meeting in Davos, where we joined leaders from business, government, civil society and academia in discussions around the theme, “Creating a Shared Future in a Fractured World.” In keeping with the focus on the global economy, MSD for Mothers and our partners made the business case for investing in maternal health, argued for greater private sector involvement in innovative financing for development, and advocated for more research on the experiences of wome

Fortune Magazine Names Merck One of World’s Most Admired Companies

Multimedia with summary

Fortune Magazine has released its annual list of the World’s Most Admired Companies. For the first time, Merck ranked first among its peers for pioneering innovation and second overall among pharmaceutical industry in the survey.

“We are honored to be recognized on Fortune’s list of Most Admired Companies,” says Ken Frazier, chairman and CEO, Merck.  “This ranking reflects our strategic focus and relentless passion for inventing new ways to save and improve lives.”

Pages

Subscribe to Merck